advertisement

Topcon

Hollander DA 2

Showing records 1 to 2 | Display all abstracts from Hollander DA

24259 Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: A meta-analysis of two phase 3 studies
Cantor LB; Liu C-C; Batoosingh AL; Hollander DA
Current Medical Research and Opinion 2009; 25: 1615-1620
24258 Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy
Nixon DR; Yan DB; Chartrand J-P; Piemontesi RL; Simonyi S; Hollander DA
Current Medical Research and Opinion 2009; 25: 1645-1653

Issue 11-3

Change Issue


advertisement

WGA Rescources